1. Essner R, Chung MH, Bleicher R, Hsueh E, Wanek L, Morton DL, Prognostic implications of thick (≥4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.Ann Surg Oncol 2002;9:754–61.
2. Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (>4.0mm) primary melanoma.Ann Surg Oncol 2000;7:160–5.
3. Cherpelis BS, Haddad F, Messina J, et al. Sentinel lymph node mlerometastases and other histology factors that predict outcome. In patients with thicker melanomas.J Am Acad Dermatol 2004;44:762–6.
4. Salti GI, Kansagra A, Warso MA, Ronan SG, Das Gupta TK, Clinical node-negative thick melanoma.Arch Surg 2002;137:291–5.
5. Reintgen DS, Rapaport DP, Tanabe KK, Ross MI. Lymphatic mapping and sentinel lymphadenectomy. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. St Louis: Quality Medical Publishing, 1989:725–44.